{
  "ptid_time": "129_S_4422_2017-03-21",
  "img_path": "/data/qiuhui/data/adni/images/129_S_4422/2017-03-21/t1.nii.gz",
  "img_finding": "Image findings: ventricular volume measures 57,259 mm³, 104.0% above the reference mean. With a Z-score of 2.38 (99.1th percentile), this represents significant enlargement; hippocampal volume measures 6,389 mm³, 10.2% below the reference mean. With a Z-score of -0.94 (17.5th percentile), this represents normal volume ; whole brain volume measures 935,891 mm³, 4.0% below the reference mean. With a Z-score of -0.50 (30.8th percentile), this represents normal volume ; entorhinal cortex volume measures 2,338 mm³, 36.3% below the reference mean. With a Z-score of -2.23 (1.3th percentile), this represents significant atrophy; fusiform gyrus volume measures 12,128 mm³, 28.7% below the reference mean. With a Z-score of -2.61 (0.4th percentile), this represents significant atrophy; middle temporal gyrus volume measures 14,976 mm³, 21.9% below the reference mean. With a Z-score of -1.90 (2.9th percentile), this represents moderate atrophy. ",
  "text_data": "Age is 75.8 years. Gender is Female. Education: 15 years. MMSE: 29.0. MoCA: 22.0. Logical Memory: 12.0. APOEε4 alleles: 0.0. Biomarker levels: Florbetapir (AV45): 1.39 SUVR (significant elevated). ",
  "true_diagnosis": "Diagnosis: MCI.",
  "gpt_diagnosis": "Reasoning: The patient shows significant ventricular enlargement and atrophy in key Alzheimer's-related regions (entorhinal cortex, fusiform gyrus, middle temporal gyrus), despite normal hippocampal volume. The MMSE is normal (29/30), but the MoCA (22/30) suggests mild cognitive impairment. Elevated AV45 (amyloid PET) supports amyloid pathology, though APOE4-negative status is less typical for AD.  \nDiagnosis: **MCI (likely due to Alzheimer's pathology)**  \nConfidence: **Medium** (high structural/amyloid evidence but discrepancy between MMSE/MoCA and lack of APOE4)",
  "timestamp": "2025-07-26T14:17:59.673958"
}